CORONA, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- MedTainer Inc. (ACOL-OTC) announced today that Aurora Cannabis
(OTCMARKETS:ACBFF,TSE:ACB) has placed its’ 7th order for thousands of MedTainers in anticipation of the mid-October start to
Canada’s legal recreational cannabis market. The company states that it anticipated and is well-prepared to fulfill the increased
influx of orders for their signature multi-functional, certified child-resistant, FDA-approved container.
The company also introduced a new size 40-dram MedTainer to the market, doubling the size of its’ signature product. This is in
keeping with the anticipated demand of consumers who will want larger quantities of retail flower cannabis and make it easier to
classify and label retail cannabis, as demanded by Canadian federal law.
MedTainer Inc. feels that these events signal a continuation of its steady Canadian expansion, predicted last year and
continuing this year once the Canadian Legislature approved cannabis for legal recreational use. MedTainer Inc. continues to see a
steady expansion in North America and anticipates that with the offer of multiple-sized, multiple-function containers this trend
will continue. MedTainer Inc. anticipates doubling its’ sales and profits in 2019.
For investor or sales information please visit MedTainer Inc. and D&C Distributors online or by phone. The company is
located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
MedTainer Inc. currently trades on the OTC under the call letters ACOL. The company’s websites are www.Medtainerinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology
products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to info@Medtainerinc.com or call (844) 226-5649. Ask for Jack Rein, National Services
Director. MedTainer can also be accessed through Twitter and Instagram at @Medtainerinc
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such
statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond
could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as
“anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that
indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in
the loss of some or all his or her investment.
